课题基金 / 基金详情

MEDICATION DEVELOPMENT FOR COCAINE ABUSERS

MEDICATION DEVELOPMENT FOR COCAINE ABUSERS
针对可卡因滥用者的药物开发
批准号:
8172305
负责人:
MICHAEL J KUHAR
金额:
$4.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30

项目摘要

项目成果

MICHAEL J KUHAR的其他基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. RTI-336, a compound first tested and characterized in our laboratories, has been approved for Phase I clinical trials in humans. As of this writing, no toxic effects were found that preclude further study, and additional studies are planned in humans. RTI-336 would be a new medication for cocaine addicts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MEDICATION DEVELOPMENT FOR COCAINE ABUSERS
  • 批准号:
    8357378
  • 项目类别:
  • 资助金额:
    $3.29万
  • 财政年份:
    2011
  • 负责人:
    MICHAEL J KUHAR
  • 依托单位:
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
  • 批准号:
    8357409
  • 项目类别:
  • 资助金额:
    $3.29万
  • 财政年份:
    2011
  • 负责人:
    MICHAEL J KUHAR
  • 依托单位:
THE CART RECEPTOR
  • 批准号:
    8357488
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    2011
  • 负责人:
    MICHAEL J KUHAR
  • 依托单位:
REGULATION OF THE CART GENE BY PROMOTER CIS-ELEMENTS
  • 批准号:
    8357437
  • 项目类别:
  • 资助金额:
    $3.29万
  • 财政年份:
    2011
  • 负责人:
    MICHAEL J KUHAR
  • 依托单位: